Avania
Private Company
Funding information not available
Overview
Avania is a specialized, global Contract Research Organization (CRO) serving the medical device and diagnostics industry. It differentiates itself by offering an integrated suite of services spanning regulatory strategy, clinical trial execution, and market access/reimbursement planning, all tailored for the MedTech development pathway. With over 300 employees and a track record of over 450 strategic advising partnerships, Avania has deep expertise in complex therapeutic areas like cardiovascular, neurovascular, and orthopedics. The company operates as a private, service-based business, generating revenue by partnering with MedTech sponsors to accelerate their regulatory approvals and market entry.
Technology Platform
Integrated service model combining regulatory strategy, clinical development, and market access/reimbursement planning specifically for medical devices, diagnostics, and digital health technologies. It is an expertise-driven platform offering full-service trial execution, functional service provision (FSP), and targeted advisory services.
Opportunities
Risk Factors
Competitive Landscape
Avania competes in the MedTech-focused segment of the global CRO market. Key competitors include large, diversified CROs with device divisions (e.g., IQVIA, Medpace) and other specialized device/diagnostic CROs (e.g., NAMSA, Clinlogix). Avania's differentiation is its pure-play MedTech focus, deep therapeutic expertise in complex areas, and integrated service model combining clinical, regulatory, and market access.